Status
Conditions
Treatments
About
One of major challenges in orthodontics is to inhibit relapse and ensure stability of treatment outcomes. Retention is the phase of orthodontic treatment that attempts to keep teeth in the corrected position after correction with orthodontic braces. Without retention there is a tendency for the teeth to return to their initial position (1). Retention is usually necessary to overcome the elastic recoil of the periodontal supporting fibers and to allow remodeling of the alveolar bone. The bonded orthodontic lingual retainer constructed from composite and orthodontic wires provides an esthetic and efficient system for maintained retention and has been shown to be an effective means of retaining aligned anterior teeth in the post treatment position in the long term. This has been in popular use as a method of retention since the late 1970s (2).
The traditional retainers, which are still in use, are multi-strand stainless steel retainers such as Penta-one® 0.0215 (Masel Orthodontics, Carlsbad, CA, USA). The main problem with multistrand stainless steel retainers is their high rate of failure. Clinical studies indicate that 5% to 37% of mandibular retainers fail during retention in some form, either bond failure or wire breakage (3-5). Reliance Orthodontic Products, Inc. (Itasca, IL, USA) recently introduced a bonded retainer system (Ortho-Flextech™ chain). This retainer's bonding is claimed to be quick and easy by reducing chairside time and eliminating laboratory costs (6). One other recently introduced retainer is Memotain™ (CA-Digital in Mettmann, Germany). Memotain is a CAD/CAM fabricated lingual retainer made of 0.014 X 0.014-inch rectangular nickel-titanium. The wire is highly flexible and custom cut to precisely adapt to the patient's lingual tooth anatomy. According to manufacturer, Memotain offers numerous perceived advantages to traditional multistranded lingual wires, including no need for wire measuring or bending, individually optimized placement, greater accuracy of fit, tighter interproximal adaptation, less tongue irritation, better durability, and resistance to microbial colonization (6). However, randomized clinical trials are necessary to determine whether these advantages are substantiated with scientific data.
A recent review by the Cochrane group concluded that to date there is insufficient evidence to single out any particular retention strategy as the preferred method: it was recommended that future studies should include true randomization, reporting of dropouts, adequate sample size calculation, and a minimum follow-up period of 3 months (8). Thus, the aims of this multicenter, randomised controlled trial are:
Full description
Trial design This study is a 3-arm parallel-group, randomized controlled trial with a 1:1 allocation ratio.
Participants, eligibility criteria, and setting
Participants are to be recruited at the Postgraduate Dental Education Center, Department of Orthodontics, in Örebro, Henrikson Orthodontics, in Malmö and Universitat Internacional de Catalunya, Department of Orthodontics, in Barcelona.
The following inclusion criteria is to be applied:
Interventions
After informed consent is obtained, the patients are going to be randomized into three groups:
Group 1: Penta-One 0.0215 inch multistranded wire
Group 2: Ortho-FlexTech stainless steel chain
Group 3: Memotain wire
Procedures For all groups the time required for taking impressions and bonding of retainers is taken by a digital timer.
Patients allocated to Group 1:
After taking impressions and when the working models are cast in hard stone, all retainers (0.0215-inch multistranded Penta-one wire) are going to be contoured by dental technicians at each center.
All retainers in the study are to be bonded using the following sequence of construction.
Patients allocated to Group 2:
Patients allocated to Group 3:
Follow-ups During the visit to the clinics all groups are to take impressions with digital scanning of the upper and the lower dentition and intraoral photographs from the dentition at baseline (directly after debond) T0, 6 months after debond (T1), one year (T2) two years (T3) and five years (T4) after debond.
The digital study models will be assessed for identifying possible side effects and deviation of individual tooth positions. For this purpose Little's Irregularity Index (LII) (9) for tooth contact displacement will be used. Patients' records will be reviewed to assess the first debond or breakage of the retainers during the observation periods.
To determine the cost-effectiveness, the overall cost of the retainers including manufacturing, time for impressions and bonding will be calculated and compared.
Failure of a retainer can occur as a result of debonding, fracture, debonding and fracture, or retainer loss. Information on the site of failure e.g. single tooth bond failure, enamel/adhesive failure, or adhesive wire failure is to be recorded in the patients' records.
Only first failures are to be counted and failure location (which tooth) is to be noted. In addition, multiple failure sites in one retainer are going to be counted as one failure. Furthermore, failure is considered when there was debonding, fracture, debonding and fracture, or retainer loss.
Outcomes The primary outcome is failure rate/breakage of the retainers during the observation period.
Secondary outcome include, complications (such as BoP, calculus, caries, gingivitis), costs and the effect of micro-etching (sand blasting) on the failure rate.
Sample size estimation The calculated sample size for each group is based on a significance level of 0.05 and 90 per cent power to detect a clinically meaningful difference of 15 per cent failure rate between the groups. The sample size calculation indicated that 97 patients would be required in each group. To compensate for dropouts, we decided to include at least 108 patients in each group (an addition of 10 per cent per group) and a total of 324 patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
324 participants in 3 patient groups
Loading...
Central trial contact
Farhan Bazargani, DDS, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal